168 filings
8-K
PGEN
Precigen Inc
19 Mar 24
Precigen Reports Full Year 2023 Financial Results and Business Updates
4:17pm
8-K
PGEN
Precigen Inc
8 Feb 24
Departure of Directors or Certain Officers
4:25pm
8-K
PGEN
Precigen Inc
8 Jan 24
Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference
8:39am
8-K
PGEN
Precigen Inc
9 Nov 23
Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
5:07pm
8-K
PGEN
Precigen Inc
9 Aug 23
Results of Operations and Financial Condition
8:15am
8-K
czzfn5 ss9bw
9 Jun 23
Departure of Directors or Certain Officers
4:32pm
8-K
6nrhm0e5y1nnm
10 May 23
Precigen Reports First Quarter 2023 Financial Results and Business Updates
8:00am
8-K
syn8ciynwg0n
4 Apr 23
Entry into a Material Definitive Agreement
9:16pm
8-K
er831ssn
13 Mar 23
Regulation FD Disclosure
6:06am
8-K
pcezzocc7mid2
6 Mar 23
Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
4:13pm
8-K
xwy5z whq35fi9r
27 Jan 23
Entry into a Material Definitive Agreement
8:31am
8-K
qcy0vsgj
24 Jan 23
Results of Operations and Financial Condition
4:10pm
8-K
ji7vg84
11 Jan 23
Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference
7:01pm
8-K
2cmcyg6ryhbbm
9 Nov 22
Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs
4:14pm
8-K
gi2wa
21 Sep 22
Precigen Names Rutul R. Shah Chief Operating Officer
5:07pm
8-K/A
jpz wb4i9
24 Aug 22
Financial Statements and Exhibits
4:28pm
8-K
94lx846j
22 Aug 22
Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics
8:47am
8-K
uupqb 3g6o
9 Aug 22
Entry into a Material Definitive Agreement
12:00am
8-K
6tlnwg b9b03qt4v
8 Aug 22
Precigen Reports Second Quarter and First Half 2022 Financial Results
4:10pm
8-K
a70jlh6uh bkk
13 Jul 22
Other Events
4:14pm